Free Trial

Nutex Health (NASDAQ:NUTX) Sets New 1-Year High - What's Next?

Nutex Health logo with Medical background

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $152.51 and last traded at $146.65, with a volume of 33020 shares traded. The stock had previously closed at $145.27.

Analyst Ratings Changes

Separately, Maxim Group increased their price target on shares of Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th.

View Our Latest Report on Nutex Health

Nutex Health Price Performance

The stock has a 50-day simple moving average of $78.57 and a 200 day simple moving average of $50.26. The company has a market cap of $682.93 million, a PE ratio of -13.16 and a beta of 0.27. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The business had revenue of $81.30 million for the quarter, compared to analysts' expectations of $81.13 million.

Insiders Place Their Bets

In other news, CFO Jon Christian Bates bought 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the purchase, the chief financial officer now owns 4,888 shares of the company's stock, valued at approximately $399,887.28. This represents a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 38.52% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Drive Wealth Management LLC acquired a new stake in shares of Nutex Health in the 4th quarter valued at $1,122,000. Legato Capital Management LLC increased its holdings in Nutex Health by 26.8% in the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock valued at $1,004,000 after buying an additional 6,697 shares during the last quarter. Baader Bank Aktiengesellschaft acquired a new stake in Nutex Health in the fourth quarter valued at $206,000. Russell Investments Group Ltd. acquired a new stake in Nutex Health in the fourth quarter valued at $672,000. Finally, American Century Companies Inc. purchased a new stake in Nutex Health during the 4th quarter worth about $1,362,000. Hedge funds and other institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Articles

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines